First Trimester Down's Syndrome Screen
First Trimester Screen for Down's Syndrome, First Trimester Screen for Down Syndrome, First Trimester Down's Syndrome Screen, PAPP-A , Antrim #31425, EPIC: LAB5775, SOFT: DOWN1
- The specimen is to be drawn at 11-13 weeks gestational age and should be accompanied by a completed prenatal screening.
- An NT measurement between 11-13 weeks is required for performance of this screen.
Specimen Collection Criteria
Collect: One Gold-top SST tube. (Minimum Whole Blood: 4.0 mL)
Physician Office/Drawsite Specimen Preparation
Let specimen clot 30-60 minutes then immediately centrifuge to separate serum from cells. Refrigerate (2-8°C or 36-46°F) the centrifuged collection tube within two hours of collection. (Minimum Serum: 1.0 mL)
Preparation for Courier Transport
Transport: Centrifuged collection tube, refrigerated (2-8°C or 36-46°F). (Minimum Serum: 1.0 mL)
- Plasma specimens.
- Severely hemolyzed, lipemic or icteric specimens.
- Specimens not collected and processed as indicated.
Monday – Friday.
Results available within 2 business days.
The screen includes quantitation of pregnancy associated plasma protein A (PAPP-A) and hCG. The result of each test is reported as an MoM (multiple of the median) that is adjusted for the patient weight and is calculated for the appropriate gestational age.
Results of the assays are combined with the NT measurement to provide an overall risk of fetal Down's syndrome. The cut-off used for the First Trimester Screen is 1:230.
In comparison to a normal pregnancy, fetal Down's syndrome results in lower PAPP-A and higher hCG and NT results. Because the calculated MoM for each test takes into account the patient's gestational age, it is essential that gestational age information is based on an ultrasound measurement. Because this is a screen for Down's syndrome, a number of positive results will be determined by further investigation to be false positives. Use of the First Trimester provides a detection rate similar to the integrated screens (85%) but with a greater false positive rate (5%).
If a pregnancy has resulted from use of a donated ovum, the age of the egg donor is used to calculate Down syndrome and Trisomy 18 risk assessments. It is therefore essential that the egg donor's date of birth or age is given to the lab with other patient information.
Open Neural Tube Defect (ONTD) Screening
ONTD screening cannot be performed by the First Trimester Screen.
The First Trimester Screen is a screen used to determine the risk of a woman having a Down's syndrome fetus. It is not a diagnostic test. The risk of Trisomy 18 is also calculated from patient age and test results; the risk is reported as increased if it is greater than 1:100.
Antrim #31425, EPIC: LAB5775, SOFT: DOWN1
Microtainer® and Vacutainer® are registered trademarks of Becton, Dickinson and Company.
UroVysion® is a registered trademark of Abbott Laboratories. ThinPrep® is a registered trademark of Hologic, Incorporated.
This directory currently reflects information only for specimens collected and/or processed at the
Farmington Hills, Grosse Pointe, Royal Oak, and Troy campuses.